TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
AdAlta Ltd. ( (AU:1AD) ) has provided an announcement.
AdAlta Ltd. announced the cessation of 4,929,060 securities due to the expiry of options or other convertible securities without exercise or conversion as of November 26, 2025. This cessation of securities may impact the company’s capital structure and could have implications for its financial strategy and stakeholder interests.
The most recent analyst rating on (AU:1AD) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on AdAlta Ltd. stock, see the AU:1AD Stock Forecast page.
More about AdAlta Ltd.
AdAlta Ltd. operates in the biotechnology industry, focusing on the development of innovative therapeutic products. The company is known for its proprietary i-body technology, which is used in the development of new drugs targeting a range of diseases.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$6.62M
For detailed information about 1AD stock, go to TipRanks’ Stock Analysis page.